Tianjin Pharmaceutical Holdings Ltd., (TJPH) Capital Operation Department was established and went into business in January, 2010. Apart from managing the stock property right and capital of the group, the department also takes charge of the investment and financing management of the group, including: 1. investment, mergers and acquisitions; equity management and the issuing of bonds. 2. The reform， splitting-up and separation of corporate system；enterprise listing；bondization of capital; capital organization.
    The Capital Operation Department mainly serves the strategic targets of TJPH, in order to accelerate the realization of the target of doubling the economic scale in 2012，the Capital Operation Department will make full use of the resources of TJPH and the investment field, through cooperation with internationally renowned investment institutions, realizing the great-leap-forward development of the group.
    The Capital Operation Department sincerely welcomes to business negotiate business and develop together from all fields:
Cooperation fields: medicinal products projects investment, including pharmaceutical production (Active Pharmaceutical Ingredients、Formulation、Chinese patent medicine )、 research and development (Research Result Transfer, Joint Research), medical distribution、 medical devices.
    Ways of cooperation: the new project is operated through establishing new companies, with the pharmaceutical group holding or sharing the stocks. TJPH can cooperate about the present projects through mergers and acquisitions, reorganization, or strategic investment. For excellent projects, the group will develop as future securitization targets.
    Geographical areas of cooperation: domestic and overseas companies.
    Cooperation targets: enterprise investors, industry investment fund, financial institutions investment departments, industry management departments.